Veeva to Acquire Crossix, the Leader in Privacy-Safe Patient Data and Analytics
Veeva Systems (NYSE:VEEV) and Crossix Solutions today announced that they have entered into a definitive agreement for Veeva to acquire Crossix, the leader in privacy-safe patient data and analytics.
- Veeva Systems (NYSE:VEEV) and Crossix Solutions today announced that they have entered into a definitive agreement for Veeva to acquire Crossix, the leader in privacy-safe patient data and analytics.
- Trusted by more than 200 pharmaceutical brands, Crossix delivers privacy-safe U.S. patient data and a best-in-class analytics platform to help maximize media and marketing effectiveness.
- Crossix has been the pioneer in patient data, privacy, and analytics, said Veeva founder and CEO Peter Gassner.
- Data includes Rx, OTC, clinical, claims, consumer, hospital, media data, and more all of which are protected by best-in-class privacy safeguards.